US drug approvals
6 approvals with a product on the US market
- Olanzapine ANDA219048 · approved 23 Jan 2026
- Sodium Bicarbonate ANDA216364 · approved 15 Jun 2023
- Glycopyrrolate ANDA212871 · approved 28 Nov 2022
- Numbrino NDA209575 · approved 10 Jan 2020
- Isoniazid ANDA040090 · approved 26 Jun 1997
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.